RESMED INC (RMD) closed fiscal year 2025 with a gross margin of 59.4 % and a net margin of 27.2 %.
RESMED INC (RMD) closed fiscal year 2025 with a gross margin of 59.4 % and a net margin of 27.2 %. The same year shows an EBITDA margin of 36.6 % and an EBIT margin of 32.7 %. The free cash flow margin was 32.3 %. Against the previous year the gross margin moved +2.7 pp and the net margin +5.4 pp. Across the period the gross margin ranges between 55.8 % in 2023 and 63.7 % in 2014. The series covers 17 fiscal years, from 2009 to 2025. Margins are expressed as a percentage of net revenue and are derived from the same figures as the income statement, taken from as-reported SEC EDGAR filings, with no restatements or adjustments of our own.
Fiscal year end: June
| 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin (%) | 60.15 % | 60.01 % | 59.63 % | 59.97 % | 62.11 % | 63.65 % | 60.24 % | 58.00 % | 58.15 % | 57.04 % | 57.32 % | 58.09 % | 57.53 % | 56.57 % | 55.78 % | 56.67 % | 59.36 % |
| EBITDA margin (%) | 26.53 % | 27.64 % | 27.15 % | 27.79 % | 28.60 % | 30.77 % | 28.73 % | 28.05 % | 26.03 % | 28.28 % | 28.01 % | 32.62 % | 33.17 % | 32.42 % | 30.71 % | 31.95 % | 36.61 % |
| EBIT margin (%) | 20.67 % | 22.01 % | 21.47 % | 21.51 % | 23.43 % | 26.05 % | 24.38 % | 23.33 % | 20.60 % | 23.15 % | 22.22 % | 27.38 % | 28.27 % | 27.96 % | 26.80 % | 28.17 % | 32.75 % |
| Net margin (%) | 15.91 % | 17.40 % | 18.26 % | 18.62 % | 20.28 % | 22.20 % | 21.02 % | 19.17 % | 16.56 % | 13.49 % | 15.52 % | 21.02 % | 14.84 % | 21.78 % | 21.25 % | 21.79 % | 27.22 % |
| FCF margin (%) | 14.03 % | 12.03 % | 17.42 % | 24.55 % | 22.40 % | 20.49 % | 19.10 % | 26.62 % | 17.02 % | 18.91 % | 14.98 % | 23.91 % | 19.83 % | 6.05 % | 13.58 % | 27.78 % | 32.29 % |
